Overview
The MLH1 gene serves as the molecular proofreader of rapidly dividing tissues, especially the colonic lining and endometrium. Partnering with PMS2 and MSH2 in the DNA mismatch repair (MMR) complex, MLH1 detects and repairs tiny base mismatches left behind during DNA replication.
Germline loss-of-function variants in MLH1 represent the single leading cause of Lynch syndrome—making proactive medical surveillance highly effective, as covered in our Lynch syndrome prevention guide.
3p22.2 (Chromosome 3)
Tumor Suppressor & DNA Repair
DNA Mismatch Repair (MMR)
Lynch syndrome & colon screening
Function of MLH1
When one inherited MLH1 copy is faulty, remaining healthy MMR protein still protects cells—until a random somatic hit disables the second copy inside a mucosal cell, triggering rapid microsatellite instability (MSI-H).
Key Aspects:
🔎 Early Colonoscopy Saves Lives
Because precancerous polyps are detected and removed painlessly via colonoscopy every 1–2 years starting in young adulthood, early screening slashes mortality sharply.
🧪 Diagnostic vs. DTC Arrays
Consumer SNP arrays cover almost none of the hundreds of private MLH1 mutations; medical diagnosis requires full clinical gene sequencing and deletion testing.
🧬 Genetic Variants (SNPs)
Clinical MLH1 testing distinguishes common promoter polymorphisms from rare high-penetrance Lynch mutations:
3:36993455
Common benign-to-low-risk promoter variant studied alongside somatic MLH1 hypermethylation in sporadic colon polyps (not classic Lynch syndrome).
~22% (Europe)
3:37048955
Rare ClinVar-pathogenic missense substitution that disrupts MLH1 protein stability and triggers hereditary Lynch syndrome cancer predisposition.
Very rare (<0.01%)
Practical Significance
✅ Strategies & Guidance
- Review Three-Generation Family History: Early-onset colon or uterine cancer (<50) warrants referral to a board-certified genetic counselor.
- Regular Screening Colonoscopies: Confirmed MLH1 carriers follow accelerated colonoscopy schedules starting around age 20–25.
- Cascade Family Testing: First-degree relatives (siblings, children, parents) can be tested definitively for a known familial variant (50% transmission probability).
⚠️ Clinical Notes & Risks
- Colorectal & Endometrial Risk: Elevated lifetime cancer risk across GI tract, uterus, ovaries, and stomach when unmonitored.
- False Reassurance from Home Kits: Normal 23andMe/Ancestry results do not rule out Lynch syndrome.
- Tumor MMR / MSI Testing: Pathology teams routinely screen colon and uterine tumors for MLH1 protein loss.
📚 Data Sources
- OMIM: #120436 (MutL Homolog 1) & #120435 (Lynch Syndrome 2)
- dbSNP & ClinVar: rs1800734, InSiGHT MMR Variant Database
- NCCN Clinical Guidelines: Genetic/Familial High-Risk Assessment (Colorectal / Lynch Syndrome)
- ESMO Clinical Practice Guidelines: Hereditary Gastrointestinal Cancers
Last Update: November 2026
Related Research Guides for MLH1
Related Genes in Tumor Suppressor
TP53
TP53 encodes the p53 protein, one of the most important tumor suppressors, often called the 'guardian…
BRCA1
BRCA1 is a tumor suppressor gene that plays a crucial role in DNA repair and maintaining…
BRCA2
BRCA2 is another important tumor suppressor gene, closely related to BRCA1 and playing a similar role…